Literature DB >> 1654151

Clinical indications and diagnostic techniques of human herpesvirus-6 (HHV-6) infection.

G R Krueger1, D V Ablashi, S F Josephs, S Z Salahuddin, U Lembke, A Ramon, G Bertram.   

Abstract

The sixth member of the human herpesvirus family, HHV-6, causes early childhood infection with subsequent latency and antibody prevalence of about 60-80%. Active infection is related to a number of acute and chronic diseases such as exanthem subitum, certain cases of infectious mononucleosis and other immunoproliferative syndromes, autoimmune disorders and so-called postinfectious chronic fatigue syndrome. The clinical diagnosis of HHV-6 associated diseases requires detailed clinical differential diagnostic procedures and meticulous serological testing with exclusion of other herpesvirus infections or cross-reactivity between such infections. Diagnostic efforts, however, are warranted by certain indications for therapeutic intervention. The current review summarizes indications, techniques and limitations for the serological diagnosis of HHV-6 infection.

Entities:  

Mesh:

Year:  1991        PMID: 1654151

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Detection of antibodies directed against human herpesvirus 6 U94/REP in sera of patients affected by multiple sclerosis.

Authors:  Elisabetta Caselli; Michela Boni; Arianna Bracci; Antonella Rotola; Claudio Cermelli; Massimiliano Castellazzi; Dario Di Luca; Enzo Cassai
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Detection of viruses in young children with fever without an apparent source.

Authors:  Joshua M Colvin; Jared T Muenzer; David M Jaffe; Avraham Smason; Elena Deych; William D Shannon; Max Q Arens; Richard S Buller; Wai-Ming Lee; Erica J Sodergren Weinstock; George M Weinstock; Gregory A Storch
Journal:  Pediatrics       Date:  2012-11-05       Impact factor: 7.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.